Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neurofibroma, Plexiform”

79 trials

Showing 20 of 79 results

Testing effectiveness (Phase 2)Study completedNCT00076102
What this trial is testing

Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas

Who this might be right for
Neurofibromatosis 1Neurofibroma, Plexiform
National Cancer Institute (NCI) 36
Testing effectiveness (Phase 2)Study completedNCT00030264
What this trial is testing

Combination Chemotherapy in Treating Patients With Neurofibromatosis and Progressive Plexiform Neurofibromas

Who this might be right for
Neurofibromatosis Type 1Precancerous Condition
Children's Hospital of Philadelphia 23
Not applicableStudy completedNCT04212351
What this trial is testing

Frameshift Peptides of Children With NF1

Who this might be right for
Neurofibromatosis Type 1
Children's National Research Institute 60
Not applicableStudy completedNCT02777775
What this trial is testing

Targeting the Mechanisms Underlying Cutaneous Neurofibroma Formation in NF1: A Clinical Translational Approach.

Who this might be right for
Cutaneous NeurofibromasNeurofibromatosis Type 1Plexiform Neurofibromas
Corewell Health West 71
Large-scale testing (Phase 3)Looking for participantsNCT07407803
What this trial is testing

Evaluation of TQ-B3234 Capsules in Patients With Symptomatic, Non-Surgical Type 1 Neurofibromatosis-Associated Plexiform Neurofibromas

Who this might be right for
Plexiform Neurofibroma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 177
Early research (Phase 1)Not Yet RecruitingNCT06502171
What this trial is testing

Study of Cabozantinib With Selumetinib for Plexiform Neurofibromas

Who this might be right for
Neurofibromatosis 1Plexiform Neurofibroma
Girish Dhall, MD 30
Testing effectiveness (Phase 2)Study completedNCT02101736
What this trial is testing

Cabozantinib for Plexiform Neurofibromas (PN) in Subjects With NF1 in Children and Adults

Who this might be right for
NF1NeurofibromatosisPlexiform Neurofibromas
University of Alabama at Birmingham 45
Early research (Phase 1)Study completedNCT04495127
What this trial is testing

Selumetinib Paediatric NF1 Japan Study

Who this might be right for
Neurofibromatosis Type 1
AstraZeneca 12
Early research (Phase 1)Ended earlyNCT00716469
What this trial is testing

Phase I Clinical Study of the Safety of Photodynamic Therapy (PDT) Using LS11 in Children With Plexiform Neurofibromas

Who this might be right for
Neurofibroma
Children's Hospital of Philadelphia 7
Not applicableWithdrawnNCT03027401
What this trial is testing

Clinical Sequencing of Cancer and Tissue Repository: OncoGenomics

Who this might be right for
NeoplasmsAdenomatous Polyposis ColiNeurofibroma, Plexiform+1 more
National Cancer Institute (NCI)
Very early researchStudy completedNCT01275586
What this trial is testing

Study of Tasigna®/Nilotinib (AMN107) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas

Who this might be right for
NeurofibromatosisNF1Neurofibromas
Indiana University 6
Testing effectiveness (Phase 2)Active Not RecruitingNCT03741101
What this trial is testing

Treatment of NF1-related Plexiform Neurofibroma With Trametinib

Who this might be right for
Neurofibromatosis 1ChildNeurofibroma, Plexiform
Region Skane 15
Testing effectiveness (Phase 2)Study completedNCT00021541
What this trial is testing

R115777 to Treat Children With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas

Who this might be right for
Neurofibroma, PlexiformNeurofibromatosis Type I
National Cancer Institute (NCI) 62
Testing effectiveness (Phase 2)Study completedNCT03231306
What this trial is testing

Phase II Study of Binimetinib in Children and Adults With NF1 Plexiform Neurofibromas

Who this might be right for
Neurofibromatosis Type 1Plexiform Neurofibroma
University of Alabama at Birmingham 45
Not applicableStudy completedNCT03531814
What this trial is testing

Medication Adherence in Children, Adolescents and Adults With Neurofibromatosis Type 1(NF1) on Clinical Treatment Trials

Who this might be right for
Neurofibromatosis 1Neurofibroma, Plexiform
National Cancer Institute (NCI) 12
Not applicableEnrolling By InvitationNCT05238909
What this trial is testing

Developing Biomarkers of Plexiform Tumor Burden in Patients With Neurofibromatosis-Type 1

Who this might be right for
Neurofibromatosis 1NF1Neurofibromatosis Type 1
Ann & Robert H Lurie Children's Hospital of Chicago 200
Large-scale testing (Phase 3)Active Not RecruitingNCT04924608
What this trial is testing

Efficacy and Safety of Selumetinib in Adults With NF1 Who Have Symptomatic, Inoperable Plexiform Neurofibromas

Who this might be right for
Neurofibromatosis 1Plexiform Neurofibroma (PN)
AstraZeneca 145
Testing effectiveness (Phase 2)Study completedNCT00396019
What this trial is testing

Study of PEG-Intron for Plexiform Neurofibromas

Who this might be right for
Plexiform Neurofibroma
University of Pittsburgh 86
Not applicableEnded earlyNCT05683678
What this trial is testing

US Selumetinib Registry

Who this might be right for
Neurofibromatosis Type 1Plexiform Neurofibromas
Alexion Pharmaceuticals, Inc. 37
Not applicableLooking for participantsNCT06360406
What this trial is testing

Real-World Treatment Study of Koselugo (Selumetinib)

Who this might be right for
Neurofibromatosis 1Neurofibroma, Plexiform
AstraZeneca 200
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation